Peptídeos e Proteínas
Os peptídeos são cadeias curtas de aminoácidos ligadas por ligações peptídicas, enquanto as proteínas são cadeias mais longas e complexas de aminoácidos que podem adotar estruturas tridimensionais funcionais. Ambos os tipos de compostos são essenciais para diversas funções biológicas, como a catálise de reações (enzimas), a defesa imunológica (anticorpos) e a sinalização celular. As proteínas possuem uma estrutura hierárquica que inclui a sequência de aminoácidos, bem como as estruturas secundária, terciária e quaternária. Os peptídeos são utilizados em terapias farmacológicas e cosméticas devido às suas propriedades biológicas específicas, como no tratamento de doenças metabólicas ou na melhoria da regeneração celular. As proteínas, por sua vez, possuem aplicações em biotecnologia, nutrição e medicina regenerativa.
Na CymitQuimica, oferecemos peptídeos e proteínas de alta pureza para pesquisa em biotecnologia e aplicações terapêuticas.
Foram encontrados 3116 produtos de "Peptídeos e Proteínas"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
L-Methionine
CAS:<p>Applications Essential aminoacid for human development. Hepatoprotectant; antidote (acetominophen poisoning); urinary acidifier.<br>References Benevenga, N.J., et al.: J. Agric. Food Chem., 22, 2 (1974), Fleisher, L.D., et al.: Clin. Endocrinol. Metab., 3, 37 (1974), Meinnel, T., et al.: Biochimie, 75, 1061 (1993),<br></p>Fórmula:C5H11NO2SCor e Forma:White To Off-WhitePeso molecular:149.213,3',5,5'-Tetraiodo Thyroformic Acid (>90%)
CAS:<p>Impurity Levothyroxine EP Impurity H; T4-Benzoic Acid (USP)<br>Applications 3,3',5,5'-Tetraiodo Thyroformic Acid (Levothyroxine EP Impurity H; T4-Benzoic Acid (USP)) is a thyroid hormone analogue and a potent Thyroxine impurity.<br>References Horst, C., et al.: Biochem. J., 261, 945 (1989), Kvetny, J., et al.: Horm. Metab. Res., 24, 322 (1992), Yamauchi, K., et al.: J. Biol. Chem., 274, 8460 (1999), Davis, P., et al.: J. Endocrinol. Invest., 25, 377 (2002),<br></p>Fórmula:C13H6I4O4Pureza:>90%Cor e Forma:White To Light BrownPeso molecular:733.803-Mercaptopropionic Acid
CAS:Produto Controlado<p>Applications 3-Mercaptopropionic Acid (cas# 107-96-0) is a compound useful in organic synthesis.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br></p>Fórmula:C3H6O2SCor e Forma:NeatPeso molecular:106.14γ-Cyclodextrin
CAS:<p>Stability Hygroscopic<br>Applications γ-Cyclodextrin is used as nanomolecular encapsulation for drug delivery and pharmaceuticals. Used in the synthesis of unilamellar vesicles.<br>References Ikeda, A. et al.: Chem. Comm., 50, 1288 (2014); Gudmundsdottir, B. et al.: J. Ocular Pharm. Ther., 30, 35 (2014);<br></p>Fórmula:C48H80O40Cor e Forma:WhitePeso molecular:1297.12Pidotimod
CAS:Produto Controlado<p>Applications Immunostimulant used in patients with cell-mediated immunodepression.<br>References Gu, C., et al.: Pharm. Res., 25, 979 (2008), Fliri, A., et al.: J. Med. Chem., 52, 8038 (2009), Giagulli, C., et al.: Int. Immunopharmacol., 9, 1366 (2009),<br></p>Fórmula:C9H12N2O4SCor e Forma:NeatPeso molecular:244.27Thyroxine 4’-O-β-D-Glucuronide
CAS:<p>Applications Thyroxine 4-O-β-D-Glucuronide is a major metabolite and glucuronide conjugate of Thyroxine (T425600) formed via the glucuronidation of the phenyl hydroxyl group.<br>References Tong, Z. et al.: Drug Metab. Dispos., 35, 2203 (2007); West, C.D. et al.: J. Clin. INvest., 42, 1134 (1963);<br></p>Fórmula:C21H19I4NO10Cor e Forma:NeatPeso molecular:952.993,5,3',5'-Tetraiodo Thyromandelic Acid (>85%)
CAS:Produto Controlado<p>Impurity Levothyroxine T4-Hydroxyacetic Acid; T4-Hydroacetic Acid (USP)<br>Stability Hygroscopic<br>Applications 3,5,3',5'-Tetraiodo Thyromandelic Acid (Levothyroxine T4-Hydroxyacetic Acid; T4-Hydroacetic Acid (USP)) is a thyroid hormone analogue, a Thyroxine (T425600) impurity.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Horst, C., et al.: Biochem. J., 261, 945 (1989), Kvetny, J., et al.: Horm. Metab. Res., 24, 322 (1992), Yamauchi, K., et al.: J. Biol. Chem., 274, 8460 (1999), Davis, P., et al.: J. Endocrinol. Invest., 25, 377 (2002),<br></p>Fórmula:C14H8I4O5Pureza:>85%Cor e Forma:Light Orange Colour To BrownPeso molecular:763.83(S)-Lisinopril-d5 Sodium
CAS:Produto ControladoFórmula:C21H26D5N3NaO5Cor e Forma:NeatPeso molecular:433.51Lopinavir Metabolite M-1
CAS:Produto Controlado<p>Applications A major metabolite of Lopinavir (L469480) . It is a COVID19-related research product.<br>References Molla, A., et al.: J. Virology, 250, 255 (1998), Sham, H., et al.: Antimicrob. Agents Chemother., 42, 3218 (1998), Kumar, G., et al.: Drug Metab. Dispos., 27, 86 (1999),<br></p>Fórmula:C37H46N4O6Cor e Forma:NeatPeso molecular:642.78Tert-butyl Acetate
CAS:Produto Controlado<p>Applications Tert-butyl Acetate is a common solvent used in the production of various industrial cleansers, thinners and adhesives and is also known as a VOC.Environmental contaminants; Food contaminants<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Mackay, D., et al.: SAR. QSAR. Enviro. Res., 23, 205 (2012); Yang, Y.S., et al.: Toxicol. Res., 26, 293 (2010);<br></p>Fórmula:C6H12O2Cor e Forma:ColourlessPeso molecular:116.163,5,3',5'-Tetraiodo Thyroaldehyde
CAS:Produto Controlado<p>Impurity Levothyroxine EP Impurity I; T4-Aldehyde (USP)<br>Applications 3,5,3',5'-Tetraiodo Thyroaldehyde (Levothyroxine EP Impurity I; T4-Aldehyde (USP)) is a Thyroid hormone analogue and a Thyroxine (T425600) analogue.<br>References Horst, C., et al.: Biochem. J., 261, 945 (1989), Kvetny, J., et al.: Horm. Metab. Res., 24, 322 (1992), Yamauchi, K., et al.: J. Biol. Chem., 274, 8460 (1999), Davis, P., et al.: J. Endocrinol. Invest., 25, 377 (2002),<br></p>Fórmula:C13H6I4O3Cor e Forma:Light Beige To BrownPeso molecular:717.80Lopinavir
CAS:<p>Stability Hygroscopic<br>Applications A selective HIV protease inhibitor. An analogue of Ritonavir. Antiviral. It is a COVID19-related research product.<br>References Sham, H.L., et al.: Antimicrob. Ag. Chemother., 42, 3218 (1998), Kumar, G.N., et al.: Drug Metab. Dispos., 27, 86 (1999), Murphy, R.L., et al.: Antiviral Ther., 4, Suppl. 3, 85 (1999)<br></p>Fórmula:C37H48N4O5Cor e Forma:White SolidPeso molecular:628.8013C6-Lys Octreotide Trifluoroacetate
CAS:Produto ControladoFórmula:C4313C6H66N10O10S2•xC2HF3O2Cor e Forma:White To Off-WhitePeso molecular:1025.2011402Bivalirudin Plus-Gly Fragment Trifluoroacetic Acid Salt (Impurity)
<p>Applications Impurity of Bivalirudin, a direct thrombin inhibitor acting as an anticoagulant through inhibition of the enzyme thrombin.<br>References Bertrand, O. et al.: Am. J. Cardio., 110, 599 (2012); Patti, G. et al.: Am. J. Cardio., 110, 478 (2012);<br></p>Fórmula:C100H141N25O34•xC2HF3O2Cor e Forma:NeatPeso molecular:2237.34 + x(114.02)Thyroxine Sodium Salt
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications One of the thyroid hormones involved in the maintenance of metabolic homeostasis. Synthesized and stored as amino acid residues of thyroglobulin, the major protein component of the thyroid follicular colloid. Synthesis and secretion are regulated by the pituitary hormone (TSH). Deiodinated in peripheral tissues to the active metabolite, liothyronine. The D-form has very little activity as a thyroid hormone, but has been used to treat hyperlipidemia.<br>References Post, A., et al.: Anal. Profiles Drug Subs., 5, 225 (1976), Nelson, J.C., et al.: Clin. Chem., 34, 1737 (1988), Fischer, D.A., et al.: Clin. Chem., 42, 135 (1996), Cavalieri, R.R., et al.: Thyroid, 7, 177 (1997),<br></p>Fórmula:C15H10I4NO4·NaCor e Forma:NeatPeso molecular:798.852,5-Dioxopyrrolidine Sacubitril
CAS:<p>Applications Sacubitril Impurity 2 is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.<br>References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);<br></p>Fórmula:C24H27NO4Cor e Forma:White To Off-WhitePeso molecular:393.48Romidepsin
CAS:Produto Controlado<p>Applications Romidepsin is a histone deacetylase inhibitor that can alter chromatin structure and gene transcription leading to multiple changes in cellular protein production. This may result in cell cycle arrest and tumor growth inhibition. Romidepsin has shown anti-proliferative activity in vitro against multiple mouse and human tumor cell lines and in vivo in human tumor xenograft models. Romidepsin can be administered with a second agent, such as a cytotoxic agent, a steroidal agent, a proteasome inhibitor, or a kinase inhibitor.<br>References Ueda, H., et al.: J. Antibiot., 47, 301 (1994), Weidle, U., et al.: Anticancer Res., 20, 1471 (2000), Kitazono, M., et al.: Cancer Res., 61, 6328 (2001), Sandor, V., et al.: Clin. Cancer Res., 8, 718 (2002),<br></p>Fórmula:C24H36N4O6S2Cor e Forma:White To Off-WhitePeso molecular:540.70Cyclosporin D
CAS:Produto Controlado<p>Applications A group of nonpolar cyclic oligopeptides with immunosupppressant activity.<br>References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),<br></p>Fórmula:C63H113N11O12Cor e Forma:Off-WhitePeso molecular:1216.643,3’,5-Triiodo-L-thyronine 4’-O-Sulfate
CAS:<p>Applications 3,3’,5-Triiodo-L-thyronine 4’-O-Sulfate is the sulfoconjugated metabolite of 3,3’,5-Triiodo-L-thyronine (T795380).<br>References Rooda, S.J. et al.: J. Clin. Endocrinol. Metab., 69, 552 (1989); Everts, M. E. et al.: Metab. Clin. Exp., 43, 1282 (1994); Pinna, G. et al.: Endocrinology, 143, 1789 (2002);<br></p>Fórmula:C15H12I3NO7SCor e Forma:NeatPeso molecular:731.04L-Methionine Sulfoxide
CAS:<p>Stability Temperature Sensitive, Hygroscopic<br>Applications An intermediate in the synthesis of the acyclic amino carboxylic acid L-Methionine sulfoximine.<br>References Lee, B., et al.: J. Biol. Chem., 283, 28361 (2008), Nordqvist, A., et al.: Bioorg. Med. Chem., 16, 5501 (2008), Balog, E., et al.: Biochem., 48, 3005 (2009),<br></p>Fórmula:C5H11NO3SCor e Forma:White To BeigePeso molecular:165.21Glucagon-d9 Trifluoroacetate
CAS:Produto ControladoFórmula:C153H216D9N43O49Sx(C2HF3O2)Cor e Forma:NeatPeso molecular:3491.8Teduglutide Trifluoroacetic Acid Salt
<p>Applications Teduglutide TFA Salt is a polypeptide consisting of 33 amino acids. It is glucagon-like peptide-2 (GLP-2) analogue that is used for the treatment of short bowel syndrome.<br>References Jeppesen, P., et al.: Gut, 54, 1224 (2005)<br></p>Fórmula:C164H252N44O55S•x(C2HF3O2)Cor e Forma:NeatPeso molecular:3752.13 + x(114.02)Thyroxine Methyl Ester
CAS:Produto Controlado<p>Applications Thyroxine Methyl Ester is the methyl ester analog of Thyroxine (T425600) with high cross reactivity with thyroxine-specific monoclonal antibodies of humans and lab animals. It is an inhibitor of malate dehydrogenase.Thyroxine Methyl Ester is suitable for malate dehydrogenase (MDH) related research.<br>References Mpoko, C.N. et al.: Clin. Chim. Acta, 146, 215 (1985); Maggio, E.T. et al.: Biochim. Biophys. Acta Enzymol., 522, 284 (1978);<br></p>Fórmula:C16H13I4NO4Cor e Forma:NeatPeso molecular:790.90Sugammadex Sodium-deuterated
CAS:Produto Controlado<p>Applications Sugammadex Sodium-deuterated, is the labaled analogue of Sugammadex Sodium (S698100), which is the first in a class of drugs called selective relaxant binding agents that offers improved termination of the paralytic effects of neuromuscular blocking agents and may have many potential peri-operative benefits.<br>References Welliver, M., et al.: Drug Des. Devel. Ther., 2, 49 (2008);<br></p>Fórmula:C72H104Na8O48S8forundeuteratedCor e Forma:NeatPeso molecular:2178.006(1R,2R)-Bortezomib
CAS:<p>Impurity Bortezomib USP Related Compound A<br>Applications (1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009)<br></p>Fórmula:C19H25BN4O4Pureza:>85%Cor e Forma:NeatPeso molecular:384.24N-2-(Hydroxyethyl)-L-valine-d4 (Technical grade)
CAS:Produto Controlado<p>Applications Labelled N-2-(Hydroxyethyl)-L-valine (H942300). Cotinine and N-(2-hydroxyethyl)valine are markers of passive exposure to tobacco smoke in children.<br>References Dempsey, D., et al.: Clin. Pharmacol. Ther., 67, 458 (2000), Smith, C., et al.: Food Chem. Toxicol., 41, 807 (20030,<br></p>Fórmula:C7H11D4NO3Cor e Forma:WhitePeso molecular:165.22Bortezomib-D8 (Major)
CAS:Produto Controlado<p>Applications Labelled Bortezomib, which the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells.d6-3%d7-10%d8-86%<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005)<br></p>Fórmula:C19H17D8BN4O4Cor e Forma:Off-WhitePeso molecular:392.29(1R,3S)-Camphoric Acid
CAS:<p>Applications (1R,3S)-Camphoric Acid is used primarily as a reagent in syntheses of crystalline structures. It is used in the preparation of polymeric transition metal dipyridylamine D-camphorate complexes.<br>References Blake, K. et al.: Crys. Growth Des., 12, 5215 (2012);<br></p>Fórmula:C10H16O4Cor e Forma:White SolidPeso molecular:200.23(R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid
CAS:Produto Controlado<p>Applications (R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid, is an amino acid building block used in peptide synthesis. With a growing peptide drug market the fast, reliable synthesis of peptides is of great importance.<br></p>Fórmula:C10H11NO2Cor e Forma:NeatPeso molecular:177.20Oxytocin Acetate
CAS:<p>Applications Oxytocin Acetate is the principal uterus-contracting and lactation-stimulating hormone of the posterior pituitary gland.<br>References Pierce, et al.: J. Biol. Chem., 199, 929 (1952), Tuppy, et al.: Biochem. Biophys. Acta, 11, 449 (1953), Cash, et al.: J. Med. Pharm. Chem., 5, 413 (1962), Nachtmann, F., et al.: Anal. Profiles Drug Subs., 10, 563 (1981),<br></p>Fórmula:C43H66N12O12S2·C2H4O2Cor e Forma:White To Off-WhitePeso molecular:1067.245-9-Leuprolide xTFA Salt
CAS:Produto Controlado<p>Applications 5-9-Leuprolide is a metabolite of Leuprolide (L330590), a gonadotropin-releasing hormone (GnRH) analogue acting as an agonist at pituitary GnRH receptors.<br>References Handelsman, David J., et al.: J. of Steroid Biochem. and Mol. Bio., 141, 113-120 (2014);Okada, Hiroaki, et al.: Pharma. Res., 8(6), 787-91 (1991)<br></p>Fórmula:C34H57N9O6·x(C2HF3O2)Cor e Forma:NeatPeso molecular:687.87+ x(114.02)N-Glycylproline
CAS:<p>Applications N-Glycylproline was found to exhibit anti-ischemic effects on the metabolism of neuroactive amino acids and indices of energy turnover in the neocortex of rats after experimental brain ischemia.<br>References Bashun, Z.N., et al.: Neurochem. J., 7, 39 (2013);<br></p>Fórmula:C7H12N2O3Cor e Forma:NeatPeso molecular:172.182Lisinopril Cyclohexyl Analogue
CAS:Produto Controlado<p>Impurity Lisinopril EP Impurity F<br>Applications Lisinopril Cyclohexyl Analogue (Lisinopril EP Impurity F) is a Lisinopril (L468985) impurity.<br>References Paraskevas, G., et al.: J. Pharm. Biomed. Anal., 29, 865 (2002),<br></p>Fórmula:C21H37N3O5Cor e Forma:NeatPeso molecular:411.54Teduglutide
CAS:<p>Teduglutide (ALX-0600) is a glucagon-like peptide-2 analog that increases intestinal absorption and can be used in research on short bowel syndrome (SBS).</p>Fórmula:C164H252N44O55SPureza:98.08%Cor e Forma:SolidPeso molecular:3752.08DL-Methionyl-DL-methionine
CAS:Produto ControladoFórmula:C10H20N2O3S2Cor e Forma:NeatPeso molecular:280.4Protoporphyrin-9
CAS:<p>Stability Light Sensitive<br>Applications Protoporphyrin-9 is the precursor to heme sites and chlorophyll.<br></p>Fórmula:C34H34N4O4Cor e Forma:NeatPeso molecular:562.66L-Thioproline
CAS:<p>Applications L-Thioproline is used to create a monolayer on gold electrodes for the determination Copper(II). L-Thioproline has shown to be an effect inhibitor of proline absorption in Saccharomyces chevalieri.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Cui, X., et. al.: Sci. China Chem., 53, 257 (2010); Magana-Schwenchke, N., Schwencke, J.: BBA-Biomembranes, 173, 313 (1969)<br></p>Fórmula:C4H7NO2SCor e Forma:NeatPeso molecular:133.17Desisobutyl-n-butyl Bortezomib
CAS:<p>Impurity Bortezomib N-Pentyl Impurity<br>Applications Desisobutyl-n-butyl Bortezomib is an impurity of Bortezomib (B675700). Bortezomib impurity 5.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Lin, G., et al.: J. Biol. Chem., 283, 34423 (2008);<br></p>Fórmula:C19H25BN4O4Cor e Forma:NeatPeso molecular:384.24N-Pyrazinylcarbonyl-L-phenylalanine Methyl Ester
CAS:<p>Applications Used for the synthesis of Bortezomib from L-phenylalanine via dipeptidyl boronic acid ester intermediates.<br>References Zhu, Y., et al.: J. Med. Chem., 52, 4192 (2009),<br></p>Fórmula:C15H15N3O3Cor e Forma:NeatPeso molecular:285.30L-Valine-d8
CAS:Produto Controlado<p>Applications Labelled analogue of L-Vailne. L-Valine is an essential amino acid and one of 20 proteinogenic amino acids. L-Valine cannot be manufactured by the body and must be acquired through diet or supplementation. L-valine is found in grains, dairy products, mushrooms, meats, peanuts and soy proteins. L-Valine has been used in studies to attenuate arrhythmias and induce hypotensive effects.<br>References Choi, C.W. et al.: Anim. Feed Sci. Technol., 102, 15 (2002); Kolarski, D. et al.: Krmiva, 30, 155 (1988); Oba, M. et al.: J. Dairy Sci., 93, 2044 (2010); Mitrega, K. et al.: Pharmacol. Res., 64, 218 (2011);<br></p>Fórmula:C52H8H3NO2Cor e Forma:NeatPeso molecular:125.20(2R,4R)-Sacubitril
CAS:<p>Applications (2R,4R)-Sacubitril is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);<br></p>Fórmula:C24H29NO5Cor e Forma:NeatPeso molecular:411.491GSK1904529A
CAS:<p>GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) .</p>Fórmula:C44H47F2N9O5SPureza:98.2% - 99.38%Cor e Forma:SolidPeso molecular:851.96Lisinopril (S,S,R)-Diketopiperazine (~90%)
CAS:<p>Impurity Lisinopril EP Impurity D<br>Stability Hygroscopic<br>Applications Lisinopril (S,S,R)-Diketopiperazine (Lisinopril EP Impurity D) is an impurity of Lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor (1).<br>References 1. Goa, K. et al.: Drugs. 1996 Oct;52(4):564-88.<br></p>Fórmula:C21H29N3O4Pureza:~90%Cor e Forma:White To Off-WhitePeso molecular:387.47β-Hydroxy Thyroxine (>90%)
CAS:Produto Controlado<p>Impurity Levothyroxine beta-Hydroxy Impurity / Levothyroxine beta-Hydroxy T4 Impurity<br>Applications It has been prepared for testing as possible antithyroid. It showed some thyromimetic activity.<br>References Wawzone, S., et al.: J. Med. Chem., 6, 442 (1963),<br></p>Fórmula:C15H11I4NO5Pureza:>90%Cor e Forma:NeatPeso molecular:792.87N-[(1S)-2-[(3-Methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide
CAS:Produto ControladoFórmula:C19H24N4O2Cor e Forma:White To Off-WhitePeso molecular:340.41951-Nitrosopyrrolidine-2-carboxylic Acid
CAS:Produto Controlado<p>Applications 1-nitrosopyrrolidine-2-carboxylic acid (cas# 2571-28-0) is a useful research chemical.<br></p>Fórmula:C5H8N2O3Cor e Forma:NeatPeso molecular:144.129(R)-Lisinopril Sodium Salt
CAS:<p>Applications R,S,S-Isomer of Lisinopril (L468985).<br>References Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)<br></p>Fórmula:C21H31N3NaO5Cor e Forma:NeatPeso molecular:428.48rhPTH (1-30) Trifluoroacetic Acid Salt Hydrate
Produto Controlado<p>Impurity Teriparatide Impurity<br>Applications A fragment of human parathyroid hormone (hPTH) peptide sequence containing the 30 N-terminal residues of hPTH.<br>References Niall, et al.: Proc. Natl. Acad. Sci., 71, 384 (1974);<br></p>Fórmula:C157H260N48O46S2•x(C2HF3O2)•y(H2O)Cor e Forma:NeatPeso molecular:3620.171140218Sacubitril Calcium
CAS:<p>Applications Sacubitril is an antihypertensive drug used in combination with valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.<br>References McMurray, J., et al.: N. Eng. J. Med., 371 (2014)<br></p>Fórmula:C24H28NOCa2Cor e Forma:NeatPeso molecular:430.52Carfilzomib (2S,4R)-Diol
Produto Controlado<p>Applications Carfilzomib (2S,4R)-Diol is a derivative of Carflizomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.<br>References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);<br></p>Fórmula:C40H59N5O8Cor e Forma:NeatPeso molecular:737.93L-Methionine-34S
CAS:<p>Applications Labelled L-Methionine, an essential aminoacid for human development. Hepatoprotectant; antidote (acetominophen poisoning); urinary acidifier.<br>References Benevenga, N.J., et al.: J. Agric. Food Chem., 22, 2 (1974), Fleisher, L.D., et al.: Clin. Endocrinol. Metab., 3, 37 (1974), Meinnel, T., et al.: Biochimie, 75, 1061 (1993),<br></p>Fórmula:C5H11NO234SCor e Forma:NeatPeso molecular:151.11(S)-Tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetic Acid
CAS:Produto ControladoFórmula:C9H16N2O3Cor e Forma:NeatPeso molecular:200.23D-Val(10)-Semaglutide
<p>D-Val(10)-Semaglutide is a semaglutide impurity. The amino acid at position 10 has been replaced by the D-form of the amino acid D-valine (D-Val). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molD-Ala(24)-Semaglutide
<p>D-Ala(24)-Semaglutide is a semaglutide impurity. The amino acid at position 24 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molSemaglutide Impurity 59
<p>D-Arg(28)-Semaglutide is a semaglutide impurity. The amino acid at position 28 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molD-His(1)-Semaglutide
<p>D-His(1)-Semaglutide is a semaglutide impurity. The amino acid at position 1 has been replaced by the D-form of the amino acid D-histidine (D-His). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/mol(S,E)-N-(1-(3-Methylbut-1-enylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
CAS:<p>R-N-(1-(3-methylbut-1-enyl)-1-oxo-3-phenylpropan-2-yl) pyrazine-2-carboxamide is a drug product that is used for the treatment of bacterial infections. The compound is an impurity in the synthesis of other compounds and is also used as an analytical standard. It is synthesized from commercially available starting materials and through custom synthesis. R-N-(1-(3-methylbut-1-enyl)-1--oxo--3--phenylpropan--2--yl)pyrazine--2--carboxamide has been shown to be metabolized by CYP450 enzymes, which are responsible for the metabolism of many drugs. R-(1-(3Methylbut 1Enylamino)-1Oxo 3Phenylpropan 2Yl)Pyrazine 2Carboxamide has not been evaluated as a drug product and therefore does not</p>Fórmula:C19H22N4O2Pureza:Min. 95%Peso molecular:338.4 g/molBortezomib intermediate I
CAS:<p>Bortezomib intermediate I is a metabolite of bortezomib, which is a research and development drug product. Bortezomib intermediate I is an impurity standard for bortezomib. Bortezomib intermediate I can be synthesized from the corresponding compound. It is an analytical standard used in pharmacopoeia and can be used as an API impurity or synthetic material in drug development. Bortezomib intermediate I has a high purity, natural origin, and a niche application. CAS No. 1248339-44-7</p>Fórmula:C25H36BN5O4Pureza:Min. 95%Cor e Forma:White PowderPeso molecular:481.4 g/molSemaglutide Impurity 60 (D-Arg 30)
<p>D-Arg(30)-Semaglutide is a semaglutide impurity. The amino acid at position 30 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molDes-His(1)-Semaglutide
<p>Des-His(1)-semaglutide is a semaglutide-related impurity. This des-amino acid form has the histidine (His) amino acid from position 1 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.</p>Fórmula:C181H284N42O58Peso molecular:3,976.5 g/molDes-Glu(3)-Semaglutide
<p>Des-Glu(3)-semaglutide is a semaglutide-related impurity. This des-amino acid form has got the glutamic acid or glutamate (Glu) amino acid from position 3 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.</p>Fórmula:C182H284N44O56Peso molecular:3,984.53 g/molD-Asp(9)-Semaglutide
<p>D-Asp(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the D-form of the amino acid D-aspartic acid (D-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molD-Ser-(12)-Semaglutide
<p>D-Ser(12)-Semaglutide is a semaglutide impurity. The amino acid at position 12 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molSemaglutide Impurity 29 (β-Asp-9)
<p>Beta-Asp-(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the beta-aspartic acid (also known as isoaspartic, isoAsp, β-Asp or beta-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molSemaglutide Impurity 51 (D-Thr 7)
<p>D-Thr(7)-Semaglutide is a semaglutide impurity. The amino acid at position 7 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molLinear Semaglutide
<p>Linear semaglutide, or simply L-Sema, is the semaglutide compound without the lipid side chain modification. It is essentially a linear version of the peptide.</p>Fórmula:C152H230N42O47Peso molecular:3,397.76 g/molD-Ser(11)-Semaglutide
<p>D-Ser(11)-Semaglutide is a semaglutide impurity. The amino acid at position 11 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molD-Ala-(19)-Semaglutide
<p>D-Ala(19)-Semaglutide is a semaglutide impurity. The amino acid at position 19 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molSemaglutide Impurity 56 (D-Glu 21)
<p>D-Glu(21)-Semaglutide is a semaglutide impurity. The amino acid at position 21 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molLisinopril EP Impurity E
CAS:<p>Lisinopril EP Impurity E is an impurity of lisinopril, which is a prescription drug used to treat high blood pressure. This impurity was found in a preparative high performance liquid chromatography (HPLC) and mass spectroscopy analysis of the drug. The molecular weight of Lisinopril EP Impurity E was determined to be 317.2 amu, which corresponds to the molecular formula C7H13NO2. The FT-IR spectrum showed that this impurity has an ammonium group at 1859 cm-1 and butanoic acid at 1647 cm-1.</p>Fórmula:C21H31N3O5Pureza:Min. 98 Area-%Cor e Forma:PowderPeso molecular:405.49 g/molSemaglutide Impurity 54 (D-Ala 18)
<p>D-Ala(18)-Semaglutide is a semaglutide impurity. The amino acid at position 18 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molD-Ser(8)-Semaglutide
<p>D-Ser(8)-Semaglutide is a semaglutide impurity. The amino acid at position 8 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molSemaglutide Impurity 101 (D-Glu 3)
<p>D-Glu(3)-Semaglutide is a semaglutide impurity. The amino acid at position 3 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molD-Thr(5)-Semaglutide
<p>D-Thr(5)-Semaglutide is a semaglutide impurity. The amino acid at position 5 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molD-Phe(6)-Semaglutide
<p>D-Phe(6)-Semaglutide is a semaglutide impurity. The amino acid at position 6 has been replaced by the D-form of the amino acid D-phenylalanine (D-Phe). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Fórmula:C187H291N45O59Peso molecular:4,113.64 g/mol(R)-3-Methyl-1-(pyrazine- 2-carboxamido)butylboronic acid
<p>The compound is a drug product, analytical, and research material. The molecule has been synthesized and purified by the company's chemists. It is not an API impurity but an impurity standard for HPLC. This compound is a synthetic chemical that does not occur naturally in any living organism. It has been developed for use in drug development and research. The compound was custom synthesized by the company's chemists to meet customer demand for high purity standards of this compound. It is used as a pharmacopoeia standard for HPLC analysis and drug development.</p>Pureza:Min. 95%3,3',5,5'-Tetraiodothyroformic acid
CAS:<p>Cymit Quimicaetic beta-D-glucosiduronic acid</p>Fórmula:C13H6I4O4Pureza:Min. 95 Area-%Cor e Forma:Off-White PowderPeso molecular:733.8 g/molLisinopril
CAS:<p>Lisinopril, an ACE inhibitor, treats hypertension, heart failure, heart attacks, and prevents diabetes-related eye and kidney issues.</p>Fórmula:C21H31N3O5Pureza:97.59% - 99.34%Cor e Forma:SolidPeso molecular:405.49(1S,2S)-Bortezomib
CAS:Produto Controlado<p>Impurity Bortezomib USP Impurity G<br>Stability Hygroscopic<br>Applications (1S,2S)-Bortezomib is an isomer of Bortezomib (B675700), proteasome inhibitor. (1S,2S)-Bortezomib has been seen to inhibit serine proteases shown to lower cellular Aβ concentrations, associated with Alzheimer’s or hypertension.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Hardy, J. et al.: Science, 297, 353 (2002); Paris, D. et al.: Mol. Med. 17, 149 (2011);<br></p>Fórmula:C19H25BN4O4Cor e Forma:NeatPeso molecular:384.24(S)-(-)-α-Methylbenzylamine
CAS:Produto Controlado<p>Applications (S)-(-)-α-Methylbenzylamine (cas# 2627-86-3) is a compound useful in organic synthesis.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br></p>Fórmula:C8H11NCor e Forma:NeatPeso molecular:121.18(2,6-Dimethylphenoxy)acetic Acid
CAS:Produto ControladoFórmula:C10H12O3Cor e Forma:NeatPeso molecular:180.204-(Phenylamino)-1-benzyl-4-piperidinecarboxamide
CAS:Produto Controlado<p>Applications Used as modulators of muscarinic receptors for treatment of CNS disorders.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Coghlan, M., et al.: J. Med. Chem., 44, 1627 (2001), Ashcroft, F., et al.: J. Clin. Invest., 115, 2047 (2005), Bryan, J., et al.: Curr. Pharm. Des., 11, 2699 (2005),<br></p>Fórmula:C19H23N3OCor e Forma:NeatPeso molecular:309.41Semaglutide impurity
CAS:<p>Lipid chain (stearic bi-acid) plus γ-glutamic acid or glutamate (γ-Glu) amino acid.</p>Fórmula:C35H63N3O13Peso molecular:733.89 g/molAlamethicin
CAS:<p>Alamethicin is isolated from Trichoderma viride. It is a channel-forming peptide antibiotic and induces voltage-gated conductance in model and cell membranes.</p>Fórmula:C92H150N22O25Pureza:98%Cor e Forma:SolidPeso molecular:1964.31CP5V
CAS:<p>CP5V, a PROTAC, degrades Cdc20, halts mitosis, and inhibits cancer growth by targeting it for VHL-mediated ubiquitination and proteasome destruction.</p>Fórmula:C46H66Cl3N9O12SPureza:98%Cor e Forma:SolidPeso molecular:1075.49Boceprevir-d9
CAS:Produto Controlado<p>Applications A labelled NS3 serine protease inhibitor of hepatitis C virus. It is a COVID19-related research product.<br>References Malcolm, B., et al.: Antimicrob. Agents Chemother., 50, 1013 (2006); Cubero, M., et al.: Virology, 370, 237 (2008); Venkatraman, S., et al.: J. Med. Chem., 49, 6074 (2006);<br></p>Fórmula:C272H9H36N5O5Cor e Forma:NeatPeso molecular:528.73(2S)-1-Nitrosopyrrolidine-2-carboxamide
CAS:Produto ControladoFórmula:C5H9N3O2Cor e Forma:NeatPeso molecular:143.14Voclosporin M1 (IM1-Diol-1) metabolite
Fórmula:C63H113N11O14Pureza:>85%Cor e Forma:NeatPeso molecular:1248.66Deschloro-4’-chloro Clomiphene Hydrochloride
CAS:Produto Controlado<p>Applications An impurity of Clomiphene (C587025).<br></p>Fórmula:C26H29Cl2NOCor e Forma:NeatPeso molecular:442.42(S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS:Produto Controlado<p>Applications (S,S)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Fórmula:C19H24N4O4Cor e Forma:NeatPeso molecular:372.42(D-His2)-Leuprolide Trifluoroacetic Acid Salt
CAS:Produto Controlado<p>Impurity Leuprolide Acetate EP Impurity B TFA salt<br>Applications Synthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal).<br>References Vilchez-Martinez, J.A., et al.: Biochem. Biophys. Res. Commun., 59, 1226 (1974), Sennello, L.T., et al.: J. Pharm. Sci., et al.: 75, 158 (1986), Wheeler, J.M., et al.: Am.J. Obstet. Gynecol., 167, 1367 (1992), Eri, L.M., et al.: J. Urol., 150, 359 (1993),<br></p>Fórmula:C59H84N16O12·x(C2HF3O2)Cor e Forma:NeatPeso molecular:1209.398(S)-Hydroxy Des(boric Acid) Bortezomib
CAS:Produto Controlado<p>Impurity Bortezomib USP Impurity J<br>Applications (S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl, C. et al.: Chem. and Eng. News, 87, 41 (2009)<br></p>Fórmula:C19H24N4O3Cor e Forma:NeatPeso molecular:356.42N-Nitroso-D,L-proline-d3
CAS:Produto Controlado<p>Applications A labelled nitrosoamino acid with oncogenic activity.<br>References Nagasawa, H.T., et al.: J. Med. Chem., 16, 583 (1973)<br></p>Fórmula:C52H3H5N2O3Cor e Forma:Off-WhitePeso molecular:147.147Teriparatide-d10
CAS:Produto ControladoFórmula:C181D10H281N55O51S2Cor e Forma:NeatPeso molecular:4127.725-Oxo-L-proline-d5
CAS:Produto Controlado<p>Applications 5-Oxo-L-proline-d5 is a labelled cyclized derivative of L-Glutamic Acid (G596960). The pyroglutamate core has potential application for synthesis of novel anti-bacterials.<br>References Mischo A. et al.: ChemBioChem., 13, 1421 (2012); Angelov P. et al.: Org. Biomol. Chem.: 10, 3472 (2012);<br></p>Fórmula:C52H5H2NO3Cor e Forma:White To Off-WhitePeso molecular:134.14(S,S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS:Produto Controlado<p>Impurity Bortezomib USP Impurity L<br>Stability Unstable in Methanol<br>Applications (R)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Fórmula:C19H24N4O4Cor e Forma:White To Off-WhitePeso molecular:372.42N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib
CAS:Produto Controlado<p>Applications N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Fórmula:C19H22N4O3Cor e Forma:White To Off-WhitePeso molecular:354.403t-Butyl 4-Bromobutanoate
CAS:Produto Controlado<p>Applications t-Butyl 4-bromobutanoate is a useful research chemical for organic synthesis and other chemical and pharmaceutical processes.<br>References Brudeli, B., et al.: Bioorg. Med. Chem., 18, 8600 (2010); Colak, S., et al.: Macromolecules, 41, 8436 (2008)<br></p>Fórmula:C8H15BrO2Cor e Forma:NeatPeso molecular:223.11Lisinopril (8R,S)-Diketopiperazine (Mixture of Diastereomers)Mps1-IN-1 dihydrochloride
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Lisinopril (L468985) impurity.<br>References Drummer, O., et al.: Arzneim.-Forsch. Drug Res., 38, 647 (1988), Simpson, K., et al.: Drugs, 59, 1149 (2000),<br></p>Fórmula:C21H29N3O4Cor e Forma:NeatPeso molecular:387.47N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers)
CAS:Produto Controlado<p>Applications N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers) is an impurity of lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor.<br>References Shinde, V., et. al.: J. Pharm. Biomed. Anal., 43, 381 (2007); Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)<br></p>Fórmula:C31H41N3O7Cor e Forma:NeatPeso molecular:567.67(S)-4-Oxo-homophenylalanine Hydrochloride
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications (S)-4-Oxo-homophenylalanine Hydrochloride is a derivative of L-Homophenylalanine (H600500); an antitumor agent.<br>References Brunner, Henri., et al.: Eur. J. Med. Chem., 25, 35 (1990)<br></p>Fórmula:C10H12ClNO3Cor e Forma:NeatPeso molecular:229.66Trofinetide (>90%)
CAS:Produto Controlado<p>Applications Trofinetide is a synthetic analogue of the endogenous N-terminus tripeptide, Glycine-Proline-Glutamate (GPE), that has shown to be neuroprotective in animal models of brain injury.<br>References Wei, H.H. et al.: J Neuroinflammation. 2009 Aug 5;6:19.<br></p>Fórmula:C13H21N3O6Pureza:>90%Cor e Forma:NeatPeso molecular:315.32Daptomycin Impurity B1-I
<p>Applications Daptomycin Impurity B1-1 is an impurity of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.<br>References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),<br></p>Fórmula:C44H66N10O15•(C2HF3O2)Cor e Forma:Off White SolidPeso molecular:975.0511402Dodecyl Polyoxyethylene (23) Aldehyde
CAS:Produto Controlado<p>Applications Polyoxyethylene (23) Lauric Acid is an intermediate in the synthesis of Bril L-23 Proline (LIFETC1), a polyethylene glycol derivative of Proline (P755995), an amino acid and precursor (with vitamin C) for collagen, the building block of the structure of tendons, ligaments, arteries, veins and muscles.<br>References Bondarenko, L.B., et al.: Int. J. Peptides., 2, 1687 (2012); Rimer, T., et al.: Biomacromolecules, 13, 2110 (2012);<br></p>Fórmula:C14H28O2(C2H4O)nCor e Forma:NeatLysipressin Acetic Acid Salt
CAS:<p>Applications Lysipressin Acetic Acid Salt, is an analog of Vasopressin (A769550), a powerful vasopressor used to modulate blood pressure. An endogenous antidiuretic hormone in most mammalian species. It is released into the blood from nerve terminals in the posterior pituitary and median eminence. It is a neurotransmitter in the central nervous system and also implicated in a variety of physiological processes such as regulating water balance by antidiuretic action.<br>References Yamashita, K. et al.: Mol. Phylo., 67, 520 (2013); Hua F. et al.: J. Emerg. Med., 44, 434 (2013); Perucca, J. et al.: J. AM. Soc. Nephrol., 19, 1721 (2008); Toba, K. et al.: Prog. Brain Res., 119, 337 (1998); Berrada, K. et al.: J. Biol. Chem., 275, 27229 (2000);<br></p>Fórmula:C46H65N13O12S2·xC2H4O2Cor e Forma:White SolidPeso molecular:1056.23 + (60.05)x2-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid
<p>Applications 2-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid is an impurity of Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.<br>References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);<br></p>Fórmula:C46H65N5O14Cor e Forma:White To Off-WhitePeso molecular:912.033Lopinavir Metabolite M-3/M-4
CAS:Produto Controlado<p>Applications A major metabolite of Lopinavir (L469480) . It is a COVID19-related research product.<br>References Molla, A., et al.: J. Virology, 250, 255 (1998), Sham, H., et al.: Antimicrob. Agents Chemother., 42, 3218 (1998), Kumar, G., et al.: Drug Metab. Dispos., 27, 86 (1999),<br></p>Fórmula:C37H48N4O6Cor e Forma:NeatPeso molecular:644.809-(2,5-d|-Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin
CAS:Produto Controlado<p>Applications 9-(2,5-d|Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin is a stereoisomer of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.<br>References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),<br></p>Fórmula:C72H99N17O25Cor e Forma:NeatPeso molecular:1602.66Linear Daptomycin Hydrochloride Salt
CAS:<p>Applications Linear Daptomycin Hydrochloride Salt is the hydrochloride salt of L466470, which is the open-conformation of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial. Daptomycin Impurity<br>References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),<br></p>Fórmula:C72H103N17O27·x(ClH)Pureza:~80%Cor e Forma:NeatPeso molecular:1638.69 + x(36.46)(AlphaS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
CAS:Produto Controlado<p>Impurity Lopinavir EP Impurity R<br>Applications (αS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide (Lopinavir EP Impurity R) is an impurity of Lopinavir (L469480), a selective HIV protease inhibitor.<br>References Chitturi, S.R., et al.: J. Pharma. Biomed. Anal., 48, 1430 (2008); Devi, A.S.L., et al.: Magnet. Reson. Chem., 45, 424 (2007);<br></p>Fórmula:C47H58N4O7Cor e Forma:NeatPeso molecular:791.0(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2yl]pyrazine-2-carboxamide
Produto ControladoFórmula:C19H22N4O4Cor e Forma:NeatPeso molecular:370.4(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride
CAS:Produto Controlado<p>Applications (αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride is a Bortezomib (B675700) intermediate which is used in the evaluation of bone-targeted proteasome inhibitors for myeloma.<br>References Agyin, J.K., et al.: Bioorg. Med. Chem. Lett., 23, 6455 (2013); Traenckner, E., et al.: EMBO. J., 13, 5433 (1994)<br></p>Fórmula:C24H37BN2O3·ClHCor e Forma:NeatPeso molecular:448.8341(alphaR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt
CAS:Produto Controlado<p>Applications Bortezomib (B675700) intermediate. A boronic acid dipeptide derivative as proteasome inhibitors.<br>References Kisselev, A., et al.: Chem. Biol., 8, 739 (2001), Kisselev, A., et al.: J. Biol. Chem., 278, 35869 (2003), Verdoes, M., et al.: Chem. Biol., 13, 1217 (2006),<br></p>Fórmula:C15H28BNO2·C2HF3O2Cor e Forma:NeatPeso molecular:379.22Bortezomib impurity 76
CAS:<p>Bortezomib impurity 76 is an analytical reference material that is used in the development and production of pharmaceuticals. It is a high purity, HPLC standard for use as an impurity in the manufacture of bortezomib API. This material is a metabolite of bortezomib and it has been shown to be pharmacologically active. Bortezomib impurity 76 can also be used as an HPLC standard for drug product analysis.</p>Fórmula:C21H44BNO2Si2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:409.56 g/molLisinopril diketopipirazine
CAS:<p>Lisinopril diketopipirazine is an analytical drug product. The CAS number for this product is 219677-82-4. This product requires a custom synthesis and impurity standard. It is synthesized from lisinopril hydrochloride and diketopiperazine hydrochloride. Lisinopril diketopipirazine is a high purity, pharmacopeia grade drug with a natural amino acid. This product has been used in research and development, niche markets, and drug development.</p>Fórmula:C21H29N3O4Pureza:90%MinCor e Forma:White To Off-White SolidPeso molecular:387.47 g/molLevothyroxine EP impurity B
CAS:<p>Please enquire for more information about Levothyroxine EP impurity B including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C15H11ClI3NO4Pureza:Min. 95%Peso molecular:685.42 g/mol[5-L-Aspartic Acid]-desmopressin
<p>Desmopressin is a synthetic drug that is used to treat diabetes insipidus and bleeding in patients who are on anticoagulants. It is also used as a diagnostic agent to distinguish between central and nephrogenic diabetes insipidus. Desmopressin is a peptide hormone with amino acid sequence L-Asp-D-Phe-L-Arg-L-Phe. It is synthesized by the combination of two amino acids, L-Aspartic Acid and L-Phenylalanine, which are then linked together through an amide bond. The synthesis of desmopressin occurs in two steps: first, the coupling of amino acid L-Aspartic Acid with the peptide linkage (N-[3-(2'-aminoethyl) carbonyl]glycine) to form the intermediate N-[3-(2'-Aminoethyl) carbonyl]-L-Aspartic Acid; second</p>Pureza:Min. 95%(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione
CAS:<p>(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione is a drug product that is an impurity standard for the API (Active Pharmaceutical Ingredient) 5α-tetrahydrospiro[benzofuran-1(3H),2'(3'H)]pyrido-[2,1'-cyclohexan]-6β,7β-(1'H)-dione. It is a metabolite of this API and can be used as a research and development analytical standard for HPLC. The CAS number for this compound is 72744-67-3. This substance has been found in natural products such as the seeds of Sesamum indicum L., Cucurbita maxima Duchesne var.</p>Fórmula:C8H10N2O42S2Pureza:Min. 95%Peso molecular:870.29 g/molN1.9,N1.9-Dimethyldesmopressin
<p>N1.9,N1.9-Dimethyldesmopressin is a synthetic analog of the natural hormone vasopressin. It is used as a drug product in research and development to study drug metabolism, but it has not been approved for use as a drug product by any regulatory agency. Impurities are determined by the USP or EP pharmacopoeia and are present at less than 1% or 2% respectively. The compound is synthesized through high purity chemical synthesis methods with purity greater than 99%.</p>Pureza:Min. 95%[4-L-Glutamic Acid]-desmopressin
<p>4-L-Glutamic Acid]-desmopressin is an analytical standard that is used to calibrate HPLC systems. This product is a high purity, synthetic, and drug development API impurity that can be used as a drug product or impurity standard. It is also available as an HPLC standard, niche, and custom synthesis. 4-L-Glutamic Acid]-desmopressin has been shown to have pharmacopoeia and CAS No.</p>Pureza:Min. 95%(S)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:<p>(S)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a drug product of the drug development industry. It is a metabolite of 3-(1,2,4-triazol-1-ylmethyl)thiazolidine-4-carboxylic acid and has been used as an analytical standard for HPLC methods. The compound has been shown to be naturally occurring in humans. (S)-3-(1,2,4-Triazol-1ylmethyl)thiazolidine 4 carboxylic acid is also used as the impurity standard for the API 3-(1,2,4 triazol 1ylmethyl)thiazolidine 4 carboxylic acid.</p>Fórmula:C9H12N2O4SPureza:Min. 95%Peso molecular:244.27 g/mol[9-Glycine]desmopressin
<p>9-Glycine Desmopressin is a drug product that has been custom synthesized for use in research and development. This compound is an impurity standard that is used to identify the 9-glycine desmopressin impurities in the HPLC method. It is also used as a synthesis intermediate for the manufacture of the API. The CAS number for this compound is [CAS NO.]. This compound was manufactured using synthetic methods and has demonstrated high purity.</p>Pureza:Min. 95%(S)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:<p>(S)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a synthetic compound that is used as an impurity standard for HPLC. It is also used in drug development and research and development of pharmaceuticals. This product was made through custom synthesis and is not natural.</p>Fórmula:C9H12N2O4SPureza:Min. 95%Peso molecular:244.27 g/molN-4,5[Acetylamino)methyl]desmopressin
<p>N-4,5[Acetylamino)methyl]desmopressin is a synthetic drug product that is used as an analytical standard for the identification and quantitation of desmopressin in pharmaceutical preparations. It is also used as an impurity standard for HPLC analysis. This product has been synthesized using a custom synthesis process, and has been shown to be suitable for use in drug development and research and development. N-4,5[Acetylamino)methyl]desmopressin is also available as a high purity HPLC standard that meets pharmacopoeia requirements.</p>Pureza:Min. 95%Levothyroxine lactose adduct
<p>Levothyroxine is a drug product that is used for the treatment of hypothyroidism. It is an analog of thyroxine, which is synthesized in the thyroid gland. Levothyroxine has been chemically synthesized and contains a lactose adduct as an impurity standard. This drug product can be used to research metabolic pathways and metabolism studies with rats. Levothyroxine lactose adducts are used in natural products research and development, such as niche specialty drugs, due to their high purity standards. The CAS number for Levothyroxine lactose adduct is 266-072-3.</p>Fórmula:C27H31I4NO14Pureza:85%MinPeso molecular:1,101.15 g/mol(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:<p>(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a research and development, impurity standard, custom synthesis, drug product, synthetic, high purity, pharmacopoeia, drug development and analytical reagent. CAS No. 162148-17-6</p>Fórmula:C9H12N2O4SPureza:Min. 95%Peso molecular:244.27 g/mol(1S,2S)-Bortezomib
CAS:<p>(1S,2S)-Bortezomib (Bortezomib) is an enantiomer of Bortezomib.</p>Fórmula:C19H25BN4O4Pureza:99.6%Cor e Forma:SolidPeso molecular:384.24Cetrorelix Acetate
CAS:<p>Cetrorelix Acetate is gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM.</p>Fórmula:C70H92ClN17O14·xC2H4O2Pureza:97.96%Cor e Forma:SolidPeso molecular:1491.11L-803087
CAS:<p>L-803087: potent sst4 receptor agonist, 0.7 nM Ki, 280x selectivity, boosts AMPA responses & seizures in mice.</p>Fórmula:C25H29F2N5O3Pureza:97.58%Cor e Forma:SolidPeso molecular:485.53Felypressin acetate
CAS:<p>Felypressin acetate (PLV-2) is an agonist of vasopressin 1 and acts on all arginine vasopressin receptors 1AS.</p>Fórmula:C48H69N13O13S2Pureza:97.06%Cor e Forma:SolidPeso molecular:1100.27(5aS,10aS)-Tetrahydrodipyrrolo[1,2-a:1',2'-d]pyrazine-3,5,8,10(2H,5aH)-tetraone
CAS:<p>The objective of this project is to design a microcontroller-based system that can monitor and diagnose the level of damage in a composite material. The system will consist of an array of sensors, actuators, and microcontrollers that are connected by a wireless network. The sensors will measure the levels of damage at each point within the composite material. The actuators will provide feedback to the sensors, adjusting their frequency and amplitude based on the level of damage detected. Microcontrollers will be responsible for analyzing data from the sensors and diagnosing any faults in the system. A miniaturized dry skin patch could be used as an alternative to traditional wet skin tests for monitoring skin health.</p>Fórmula:C10H10N2O4Pureza:Min. 95%Peso molecular:222.2 g/molD-Ile-23-semaglutide trifluoroacetate
<p>D-Ile(23)-Semaglutide trifluoroacetate is a semaglutide impurity. The amino acid at position 23 has been replaced by the D-form of the amino acid D-isoleucine (D-Ile). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Pureza:Min. 95%MEDICA16
CAS:<p>MEDICA16: GPR40 agonist, GPR120 partial agonist, ATP-citrate lyase inhibitor, lowers TG, boosts insulin sensitivity in muscle.</p>Fórmula:C20H38O4Pureza:99.62% - 99.87%Cor e Forma:White SolidPeso molecular:342.51AZD-1656
CAS:<p>AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2</p>Fórmula:C24H26N6O5Pureza:97.07% - 99.37%Cor e Forma:SolidPeso molecular:478.5(Iso)-MS4322
CAS:<p>(Iso)-MS4322 ((Iso)-YS43-22) is a protein arginine methyltransferase 5 (PRMT5 ) degrader with potential anticancer activity.</p>Fórmula:C55H76N10O12SPureza:99.05% - 99.79%Cor e Forma:SolidPeso molecular:1101.32STAT3 degrader-2
CAS:<p>STAT3 Degrader-2 is a PROTAC-based compound that effectively reduces the total STAT3 protein levels, and is utilized in the research of cancer and various</p>Fórmula:C59H62N9O13PPureza:98%Cor e Forma:SolidPeso molecular:1136.15Duostatin 5
CAS:<p>Duostatin 5 (Duo-5) is a sea hare toxin analog commonly used in the synthesis of ADC compounds.</p>Fórmula:C40H69N9O6Pureza:96.98%Cor e Forma:SolidPeso molecular:772.03Pidotimod diketopiperazine-6-propanoic acid
CAS:<p>Pidotimod is an impurity in the drug product, which is a synthetic diketopiperazine-6-propanoic acid. Pidotimod is an impurity standard that is used in the development of drugs and as a pharmacopoeia. It has been shown to be metabolized by human liver microsomes and human erythrocytes.</p>Fórmula:C9H12N2O4SPureza:Min. 95%Peso molecular:244.27 g/molReldesemtiv
CAS:<p>Reldesemtiv (CK-2127107) boosts exercise capacity, targeting fast muscle troponin, EC50 3.4 μM.</p>Fórmula:C19H18F2N6OPureza:97.27%Cor e Forma:SolidPeso molecular:384.38XY028-140
CAS:<p>XY028-140 is a selective CDK4/6 inhibitor and degrader, acting via PROTAC with ligands for Cereblon and CDK in cancer cells.</p>Fórmula:C39H40N10O7Pureza:98.59%Cor e Forma:SolidPeso molecular:760.8[Trp(O)25]-Semaglutide
<p>Semaglutide impurity.</p>Fórmula:C187H291N45O60Peso molecular:4,129.64 g/molC004019
CAS:<p>C004019 is a small molecule PROTAC capable of targeting tau for selective protein degradation from the cell, while recruiting tau and E3 ligase (Vhl) for</p>Fórmula:C49H70N12O9S2Pureza:99.89%Cor e Forma:SoildPeso molecular:1035.29LGD-6972
CAS:<p>LGD-6972 is an antagonist of glucagon receptor.</p>Fórmula:C43H46N2O5SPureza:98.8% - 99.62%Cor e Forma:SolidPeso molecular:702.9AMG 837 calcium hydrate
CAS:<p>AMG 837 calcium hydrate is a potent GPR40 agonist with an EC50 of 13 nM.</p>Fórmula:C52H44CaF6O8Pureza:98.07%Cor e Forma:SolidPeso molecular:950.97Marizomib
CAS:<p>Marizomib is a novel irreversible brain-permeable proteasome inhibitor that inhibits CT-L, CT-T-laspase-like, and trypsin-like 20S proteasomes.Cost-effective and quality-assured.</p>Fórmula:C15H20ClNO4Pureza:98.03% - 99.41%Cor e Forma:SolidPeso molecular:313.78c-Kit-IN-7
CAS:<p>c-Kit-IN-7 (compound 104) serves as an effective inhibitor of c-Kit, exhibiting an IC50 of 10 nM or less. It plays a crucial role in cancer research.</p>Fórmula:C27H32FN7O3Cor e Forma:SolidPeso molecular:521.59(2S,4S)-Sacubitril
CAS:<p>(2S,4S)-Sacubitril (Sacubitril Impurity C) is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor.</p>Fórmula:C24H29NO5Pureza:98%Cor e Forma:SolidPeso molecular:411.49Tabimorelin hemifumarate
CAS:<p>orally active ghrelin receptor (GHS-R1a) agonist</p>Fórmula:C32H40N403C4H404Pureza:98%Cor e Forma:SolidPeso molecular:586.72SSTR5 antagonist 6
CAS:<p>SSTR5 antagonist 6, an orally active antagonist specific to the somatostatin receptor subtype 5 (SSTR5), exhibits an IC50 value of 24 nM. This compound is utilized in researching type 2 diabetes [1].</p>Fórmula:C22H28ClN3O4Cor e Forma:SolidPeso molecular:433.93L-796778 acetate
CAS:<p>L-796778 acetate is a selective sst3 receptor agonist. In CHO-K1 cells expressing hsst3 receptors, it acts as a partial agonist that inhibits Forskolin-induced cAMP production, with an IC50 value of 18 nM. Additionally, L-796778 acetate exhibits anticonvulsant properties.</p>Fórmula:C31H44N6O9Cor e Forma:SolidPeso molecular:644.716(S)-dHTC1
CAS:<p>(S)-dHTC1 is a molecular glue degrader specifically targeting the transcriptional coactivator ENL. It exhibits high affinity binding to E3 ligase only upon formation of the ENL:(S)-dHTC1 complex, with an IC50 of 93 nM. In MV4;11 cells, (S)-dHTC1 degrades ENL with a DC50 of 26 nM. This compound can be utilized for acute myeloid leukemia research.</p>Fórmula:C33H40N8O6SCor e Forma:SolidPeso molecular:676.786PIN1 ligand-2
CAS:<p>PIN1ligand-2 (Intermediate M6) is a ligand designed for PROTAC target proteins (Ligands for Target Protein for s). It can be utilized in the synthesis of PROTACT(Rac)-P1D-34.</p>Fórmula:C15H25ClN2O6SCor e Forma:SolidPeso molecular:396.887Pateamine A
CAS:<p>Pateamine A: marine-sourced macrolide from Mycale hentscheli; anticancer, antiviral, and translation inhibitor.</p>Fórmula:C31H45N3O4SCor e Forma:SolidPeso molecular:555.77FK-565
CAS:<p>FK-565 is a ligand of nucleotide-binding oligomerization domain-1 (NOD1) that induces a mouse model of arteritis.</p>Fórmula:C22H38N4O9Cor e Forma:SolidPeso molecular:502.559[O1(Ac)]8-Octreotide (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(2R,3R)-1-acetoxy-3-hydroxybutan-2-yl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C51H68N10O11S2Cor e Forma:Off-White PowderPeso molecular:1060.45105[Lys(Ac)]5-Octreotide (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFórmula:C51H68N10O11S2Cor e Forma:Off-White PowderPeso molecular:1060.45105[Phe(Ac)]1-Octreotide (N-Acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C51H68N10O11S2Cor e Forma:Off-White PowderPeso molecular:1060.45105[Ser(Ac)]4-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-N-acetyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFórmula:C61H86N16O13Cor e Forma:Off-White PowderPeso molecular:1250.65603Insulin Human (COLD SHIPMENT REQUIRED) (DISCONTINUED)
CAS:Insulin and its saltsFórmula:C257H383N65O77S6Cor e Forma:White CrystalsPeso molecular:5803.63765[MetO8]-Teriparatide
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C181H291N55O52S2Cor e Forma:Off-White PowderPeso molecular:4131.12586[D-Ser]-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Fórmula:C59H84N16O12Cor e Forma:Off-White PowderPeso molecular:1208.64546Glucagon (HUMAN)
CAS:<p>Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoi</p>Fórmula:C153H225N43O49SCor e Forma:White PowderPeso molecular:3480.6157[MetO18]-Teriparatide
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C181H291N55O52S2Cor e Forma:Off-White PowderPeso molecular:4131.12586[L-Leu]6-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-L-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Fórmula:C59H84N16O12Cor e Forma:Off-White PowderPeso molecular:1208.64546Octreotide Acetate
CAS:<p>Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoi</p>Fórmula:C49H66N10O10S2·xC2H4O2Cor e Forma:White PowderPeso molecular:1018.44048[Cys(Ac)]1-Oxytocin (N-Acetyl-L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-->6)-disulfide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C45H68N12O13S2Cor e Forma:Off-White PowderPeso molecular:1048.44702[MetO8,18]-Teriparatide
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C181H291N55O53S2Cor e Forma:Off-White SolidPeso molecular:4147.12077[Asp]5-Oxytocin (L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-aspartyl-L-cysteinyl-L-prolyl-L-leucyl-glycinamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C43H65N11O13S2Cor e Forma:Off-White PowderPeso molecular:1007.42047Isocyclosporin A
CAS:Lactams, nesoiFórmula:C62H111N11O12Cor e Forma:White Off-White PowderPeso molecular:1201.84137Cyclosporin H
CAS:<p>Lactams, nesoi</p>Fórmula:C62H111N11O12Cor e Forma:White Off-White SolidPeso molecular:1201.84137[Pro(Ac)]1-Leuprolide (5-Oxo-N-acetyl-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFórmula:C61H86N16O13Cor e Forma:Off-White PowderPeso molecular:1250.65603D-[Asp]5-Oxytocin (L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-D-aspartyl-L-cysteinyl-L-prolyl-L-leucyl-glycinamide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C43H65N11O13S2Cor e Forma:Off-White PowderPeso molecular:1007.42047[D-His]-Leuprolide (5-Oxo-L-prolyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFórmula:C59H84N16O12Cor e Forma:Off-White PowderPeso molecular:1208.64546Ref: 4Z-PB-122011
Produto descontinuadoRef: 4Z-PS-189128
Produto descontinuadoRef: 4Z-F-074001
Produto descontinuadoRef: 4Z-PC-5428
Produto descontinuadoGlatiramer-d7
CAS:Fórmula:C9H4NO3D7·C6H14N2O2·C5H9NO4·C3H7NO2·C2H4OPeso molecular:188.24 146.19 147.13 89.09 60.05Ref: 4Z-G-202
Produto descontinuadoRef: 4Z-PG-194001
Produto descontinuadoRef: 4Z-T-241009
Produto descontinuadoRef: 4Z-PL-121012
Produto descontinuadoRef: 4Z-PV-095008
Produto descontinuadoRef: 4Z-M-4731
Produto descontinuadoRef: 4Z-H-046002
Produto descontinuadoRef: 4Z-PD-8219
Produto descontinuadoRef: 4Z-PD-122023
Produto descontinuadoRef: 4Z-PV-095013
Produto descontinuadoRef: 4Z-S-082108
Produto descontinuadoRef: 4Z-M-198004
Produto descontinuadoGlatiramer acetate
CAS:Fórmula:C9H11NO3·C6H14N2O2·C5H9NO4·C3H7NO2·C2H4O2Peso molecular:181.19 146.19 147.13 89.09 60.05Ref: 4Z-G-201
Produto descontinuadoRef: 4Z-PD-122038
Produto descontinuadoRef: 4Z-PL-121006
Produto descontinuadoRef: 4Z-PC-5433
Produto descontinuado
![N-[(1S)-2-[(3-Methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM291300.webp&w=3840&q=75)
![(AlphaS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD476505.webp&w=3840&q=75)
![(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2yl]pyrazine-2-carboxamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FH805105.webp&w=3840&q=75)
![[5-L-Aspartic Acid]-desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA173260.webp&w=3840&q=75)
![(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIT145578.webp&w=3840&q=75)
![[4-L-Glutamic Acid]-desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIG173261.webp&w=3840&q=75)
![[9-Glycine]desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIG173262.webp&w=3840&q=75)
![N-4,5[Acetylamino)methyl]desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA173214.webp&w=3840&q=75)
![(5aS,10aS)-Tetrahydrodipyrrolo[1,2-a:1',2'-d]pyrazine-3,5,8,10(2H,5aH)-tetraone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIT145577.webp&w=3840&q=75)
![[Trp(O)25]-Semaglutide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIS27853.webp&w=3840&q=75)
![[9,10]-Cyclo Bivalirudin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F4Z%2Fthumb-webp%2FPB-122011.webp&w=3840&q=75)
